Ethema Health Corporation
GRST
$0.00
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 228.03% | 214.17% | 229.20% | 170.58% | 30.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 228.03% | 214.17% | 229.20% | 170.58% | 30.39% |
| Cost of Revenue | 242.63% | 200.86% | 212.86% | 183.54% | 1.26% |
| Gross Profit | 210.86% | 226.30% | 244.35% | 154.11% | 97.05% |
| SG&A Expenses | 155.72% | 12.31% | 139.69% | 176.11% | -28.23% |
| Depreciation & Amortization | 70.89% | 68.05% | 81.36% | 76.44% | 9.21% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 193.08% | 78.75% | 165.67% | 172.38% | -13.16% |
| Operating Income | 305.64% | 250.57% | 175.50% | -182.58% | 84.94% |
| Income Before Tax | -230.55% | 105.27% | 33.59% | -139.82% | 62.31% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -226.44% | 106.61% | 36.49% | -136.53% | 53.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -100.00% |
| Net Income | -226.44% | 106.61% | 18.68% | -136.53% | 17.59% |
| EBIT | 305.64% | 250.57% | 175.50% | -182.58% | 84.94% |
| EBITDA | 2,209.39% | 315.62% | 349.52% | -282.70% | 103.16% |
| EPS Basic | -- | 100.00% | 100.00% | 0.00% | 100.00% |
| Normalized Basic EPS | -- | 100.00% | 100.00% | 0.00% | 100.00% |
| EPS Diluted | -- | 100.00% | 100.00% | 0.00% | 100.00% |
| Normalized Diluted EPS | -- | 100.00% | 100.00% | 0.00% | 100.00% |
| Average Basic Shares Outstanding | -0.24% | 7.20% | 107.19% | 107.23% | 107.68% |
| Average Diluted Shares Outstanding | -0.24% | 7.20% | 107.19% | 107.23% | 107.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |